Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir plus Ritonavir in Antiretroviral-Experienced Patients in the US

Author： Simpson Kit N.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.7, 2007-01, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Lopinavir/Ritonavir Tablets Compared with Atazanavir plus Ritonavir in Antiretroviral-Experienced Patients in the UK, France, Italy and Spain

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 807-817

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir in Antiretroviral-Naive Patients: Modelling the Combined Effects of HIV and Heart Disease

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir superior choice for ART-experienced patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Atazanavir/ritonavir lays siege to lopinavir/ritonavir in the CASTLE

By  

Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

By van Wyk Jean   Qaqish Roula   Hollar Kimberly   White Kelly   D’’Amico Ronald   Norton Michael   Chiu Yi-Lin   King Martin  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 103-113

Future Medicine

Access to resources Recommend Favorite